BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38165313)

  • 1. Critical insights into the evolving drug-approval process in China.
    Nikanjam M; Kurzrock R
    Cancer; 2024 Mar; 130(5):665-667. PubMed ID: 38165313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated Approval Is Not Conditional Approval: Insights From International Expedited Approval Programs.
    Mehta GU; de Claro RA; Pazdur R
    JAMA Oncol; 2022 Mar; 8(3):335-336. PubMed ID: 35050302
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory watch: Innovative drug availability in China.
    Shao L; Xu L; Li Q; Chakravarthy R; Yang Z; Kaitin KI
    Nat Rev Drug Discov; 2016 Nov; 15(11):739-740. PubMed ID: 27765941
    [No Abstract]   [Full Text] [Related]  

  • 4. Has the food and drug administration changed the drug approval process?
    Somberg JC
    Am J Ther; 2011 May; 18(3):179. PubMed ID: 21566467
    [No Abstract]   [Full Text] [Related]  

  • 5. Backlog cripples China's drug regulator.
    Nat Biotechnol; 2015 Jun; 33(6):577. PubMed ID: 26057962
    [No Abstract]   [Full Text] [Related]  

  • 6. U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations.
    Zuabi N; Patel B; Langdorf MI
    West J Emerg Med; 2016 Nov; 17(6):741-746. PubMed ID: 27833682
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving Landscape of US Food and Drug Administration Drug Approval in the Era of Precision Oncology: Finding the Right Balance Between Access and Safety.
    Kuderer NM; Lyman GH
    J Clin Oncol; 2018 Jun; 36(18):1773-1776. PubMed ID: 29742010
    [No Abstract]   [Full Text] [Related]  

  • 8. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process.
    Roden DM; Temple R
    Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869
    [No Abstract]   [Full Text] [Related]  

  • 9. Food and drug administration approval process for dermatology drugs in the United States.
    Boozalis E; Semenov YR; Kwatra SG
    J Dermatolog Treat; 2018 Sep; 29(6):536-538. PubMed ID: 29304565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the drug approval process between United States and Japan].
    Akera T
    Nihon Yakurigaku Zasshi; 2000 Jul; 116(1):57. PubMed ID: 10976456
    [No Abstract]   [Full Text] [Related]  

  • 11. Lorcaserin for weight loss: insights into US Food and Drug Administration approval.
    Miller LE
    J Acad Nutr Diet; 2013 Jan; 113(1):25-30. PubMed ID: 23260720
    [No Abstract]   [Full Text] [Related]  

  • 12. Food and Drug Administration Drug Approval Process: A History and Overview.
    Williams CT
    Nurs Clin North Am; 2016 Mar; 51(1):1-11. PubMed ID: 26897420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FDA drug approval process: focus on pediatric labeling.
    Brummel GL
    Neonatal Netw; 2001 Apr; 20(3):49-51. PubMed ID: 12144214
    [No Abstract]   [Full Text] [Related]  

  • 14. Status and thoughts of Chinese patent medicines seeking approval in the US market.
    Lei X; Chen J; Liu CX; Lin J; Lou J; Shang HC
    Chin J Integr Med; 2014 Jun; 20(6):403-8. PubMed ID: 24952167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of clinical trials in the Food and Drug Administration approval process for cardiovascular devices.
    Sapirstein W; Alpert S; Callahan TJ
    Circulation; 1994 Apr; 89(4):1900-2. PubMed ID: 8149556
    [No Abstract]   [Full Text] [Related]  

  • 16. The drug lag issue: a 20-year review of China.
    Li X; Yang Y
    Invest New Drugs; 2021 Oct; 39(5):1389-1398. PubMed ID: 33928468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics: tailoring the drug approval process for designer drugs.
    Crews M
    J Contemp Health Law Policy; 2008; 24(2):363-98. PubMed ID: 18754401
    [No Abstract]   [Full Text] [Related]  

  • 18. The FDA and "privatization"--the drug approval process.
    Rutherford EM
    Food Drug Law J; 1995; 50 Spec():203-25. PubMed ID: 10343044
    [No Abstract]   [Full Text] [Related]  

  • 19. Assuring the safe use of medications: the drug approval process and improving treatment decisions. Introduction.
    Pathak DS; Escovitz A
    Clin Ther; 1998; 20 Suppl C():C1-3. PubMed ID: 9915083
    [No Abstract]   [Full Text] [Related]  

  • 20. The ODAC Chronicles: Part 3. The FDA's philosophy and process for cancer drug evaluation and approval.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):1-5. PubMed ID: 15757431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.